ACL - Anterior Cruciate Ligament Rupture

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Arthrex
ArthrexCA - Santa Barbara
2 programs
1
Bio-ACLPhase 11 trial
Bio ACLN/A1 trial
Active Trials
NCT03294759UnknownEst. Dec 2024
NCT03294720CompletedEst. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ArthrexBio-ACL
ArthrexBio ACL

Clinical Trials (2)

NCT03294720ArthrexBio-ACL

BioACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series

Start: Jan 2018Est. completion: Dec 2022
Phase 1Completed
NCT03294759ArthrexBio ACL

Bio ACL Reconstruction Amnion Collagen Matrix Wrap and Stem Cells

Start: Sep 2017Est. completion: Dec 2024
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space